Matches in Wikidata for { <http://www.wikidata.org/entity/Q86125358> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q86125358 description "artículu científicu espublizáu n'avientu de 2014" @default.
- Q86125358 description "im Dezember 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86125358 description "scientific article published on 01 December 2014" @default.
- Q86125358 description "wetenschappelijk artikel" @default.
- Q86125358 description "наукова стаття, опублікована в грудні 2014" @default.
- Q86125358 name "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 name "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 type Item @default.
- Q86125358 label "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 label "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 prefLabel "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 prefLabel "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 P1433 Q86125358-8CF461EC-BA0B-48CC-AE72-2B32EEF0109B @default.
- Q86125358 P1476 Q86125358-68BB4944-E60A-4D5E-9003-7634601B23A4 @default.
- Q86125358 P2093 Q86125358-9F7EBD49-549F-4642-92B6-71C2051D599E @default.
- Q86125358 P304 Q86125358-57E388CB-77BA-4236-B93A-FA6E1E1A8CF1 @default.
- Q86125358 P31 Q86125358-67C0C1B5-CFE9-42C3-9690-C3DC2E83B35A @default.
- Q86125358 P31 Q86125358-9944c97f-ea18-4b7a-af10-5c6ad0c5b4ef @default.
- Q86125358 P356 Q86125358-122C12B9-07A1-4EDE-9ABE-EE6B2F4040A1 @default.
- Q86125358 P433 Q86125358-96F4CCE9-EFC2-4706-9B65-96066FE5DE08 @default.
- Q86125358 P478 Q86125358-831AA2C7-88E4-4745-892E-5AB285310108 @default.
- Q86125358 P50 Q86125358-795C55DF-6198-4A62-B323-6DD1CA62ADD4 @default.
- Q86125358 P50 Q86125358-EFB79E1C-1DAE-4A2F-AE84-F3AF38068D2D @default.
- Q86125358 P577 Q86125358-4909EA29-32A8-4F3C-8EBE-22A034BF9536 @default.
- Q86125358 P698 Q86125358-99451389-576A-41CD-887D-DAEC6AA8CFD9 @default.
- Q86125358 P356 J.AJKD.2014.10.002 @default.
- Q86125358 P698 25455093 @default.
- Q86125358 P1433 Q4744250 @default.
- Q86125358 P1476 "GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?" @default.
- Q86125358 P2093 "Amit X Garg" @default.
- Q86125358 P304 "841-844" @default.
- Q86125358 P31 Q13442814 @default.
- Q86125358 P31 Q871232 @default.
- Q86125358 P356 "10.1053/J.AJKD.2014.10.002" @default.
- Q86125358 P433 "6" @default.
- Q86125358 P478 "64" @default.
- Q86125358 P50 Q37385693 @default.
- Q86125358 P50 Q42934232 @default.
- Q86125358 P577 "2014-12-01T00:00:00Z" @default.
- Q86125358 P698 "25455093" @default.